Hospital
Bay Park Community Hospital
Bay Park Community Hospital was paid $16.39M by Medicaid between Jan 2018 and Dec 2024, across 243 billing codes. Its largest line is 99283, emergency room visit (moderate) — 17% of everything it billed.
33Billing provider infoBAY PARK COMMUNITY HOSPITAL
OREGON, OH 43616
OREGON, OH 43616
33aNPI1598765539assigned 07/29/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$16.39M
24GClaims346,537
24DCodes billed243
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#57 of 101
Median peer was paid$22.32M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,015 | $1.10M | |
| 2019 | 25,271 | $1.21M | |
| 2020 | 14,791 | $946K | |
| 2021 | 16,066 | $1.03M | |
| 2022 | 24,815 | $1.53M | |
| 2023 | 130,844 | $6.31M | |
| 2024incomplete | 108,735 | $4.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 25,230 | 23,466 | $2.86M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 31,594 | 17,742 | $2.27M |
| 96361 | Intravenous infusion, hydration; each additional hour | 11% | 5,805 | 4,083 | $1.73M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 10% | 13,528 | 11,935 | $1.72M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.4% | 2,124 | 1,696 | $549K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.2% | 5,897 | 3,524 | $531K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.2% | 3,836 | 3,088 | $528K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.7% | 3,921 | 3,380 | $440K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.5% | 1,623 | 1,323 | $408K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 3,548 | 3,187 | $345K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.0% | 4,321 | 1,323 | $320K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.8% | 1,732 | 789 | $296K |
231 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.7% | 2,195 | $285K |
| 59025 | Fetal non-stress test | 1.5% | 1,841 | $243K |
| G0378 | Hospital observation service, per hour | 1.4% | 3,136 | $229K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.3% | 761 | $214K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,970 | $163K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 697 | $159K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 724 | $158K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,453 | $145K |
| 80053 | Comprehensive metabolic panel | <1% | 14,584 | $137K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,313 | $130K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 685 | $124K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,536 | $110K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 458 | $103K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 378 | $99K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 137 | $92K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 736 | $79K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 859 | $78K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 849 | $76K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,642 | $68K |
| 76801 | <1% | 656 | $65K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 149 | $54K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 24,485 | $52K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,039 | $52K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 523 | $52K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 609 | $49K |
| 81514 | <1% | 310 | $49K | |
| 84439 | <1% | 2,877 | $48K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,640 | $41K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,480 | $41K |
| 97162 | <1% | 834 | $40K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 190 | $40K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,523 | $38K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,379 | $36K |
| 95811 | <1% | 52 | $33K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 214 | $33K |
| 80061 | Lipid panel | <1% | 2,327 | $30K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,500 | $28K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 658 | $28K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 262 | $27K |
| 96367 | <1% | 706 | $26K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 493 | $26K |
| 86780 | <1% | 1,433 | $26K | |
| 76830 | Ultrasound, transvaginal | <1% | 647 | $24K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 202 | $23K |
| 82607 | <1% | 978 | $21K | |
| 74018 | <1% | 564 | $20K | |
| 86850 | <1% | 812 | $20K | |
| H1000 | Prenatal care, at-risk assessment | <1% | 722 | $19K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,403 | $17K |
| 72100 | <1% | 486 | $16K | |
| 71250 | <1% | 184 | $16K | |
| 73562 | <1% | 820 | $16K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 82 | $15K |
| 84702 | <1% | 1,007 | $15K | |
| 82728 | <1% | 876 | $14K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 308 | $14K |
| 86787 | <1% | 546 | $14K | |
| 83735 | <1% | 6,142 | $13K | |
| 93017 | <1% | 178 | $13K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 579 | $13K |
| 76536 | <1% | 116 | $13K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 98 | $13K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,609 | $12K |
| 85027 | <1% | 1,680 | $12K | |
| 87340 | <1% | 747 | $12K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,295 | $12K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 379 | $11K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 564 | $11K |
| 86900 | <1% | 841 | $11K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 81 | $11K |
| 80076 | <1% | 969 | $11K | |
| 70496 | <1% | 29 | $10K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,378 | $10K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,017 | $10K |
| 86803 | <1% | 776 | $10K | |
| 93975 | <1% | 81 | $9K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 39 | $9K |
| 86140 | <1% | 920 | $9K | |
| 83540 | <1% | 963 | $9K | |
| 73630 | <1% | 728 | $9K | |
| 73030 | <1% | 535 | $9K | |
| 70491 | <1% | 29 | $8K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 659 | $8K |
| 90715 | <1% | 507 | $8K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 618 | $8K |
| 86762 | <1% | 542 | $7K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 563 | $7K |
| 97010 | <1% | 197 | $7K | |
| 84484 | <1% | 4,219 | $7K | |
| 59430 | <1% | 61 | $7K | |
| 82570 | <1% | 831 | $7K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,812 | $6K |
| 82950 | <1% | 555 | $6K | |
| 83550 | <1% | 798 | $6K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 46 | $6K |
| 97166 | <1% | 155 | $6K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 912 | $5K |
| 82746 | <1% | 536 | $5K | |
| 97116 | <1% | 348 | $5K | |
| 70486 | <1% | 82 | $5K | |
| 86901 | <1% | 841 | $5K | |
| 76770 | <1% | 37 | $5K | |
| 73610 | <1% | 526 | $5K | |
| 83970 | <1% | 172 | $5K | |
| 85014 | <1% | 563 | $5K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 129 | $5K |
| 84481 | <1% | 334 | $5K | |
| 73130 | <1% | 402 | $5K | |
| 81025 | <1% | 7,553 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 713 | $4K |
| 83525 | <1% | 175 | $4K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 122 | $4K |
| 71271 | <1% | 25 | $4K | |
| 0012A | <1% | 93 | $3K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 27 | $3K |
| 73502 | <1% | 199 | $3K | |
| 81003 | <1% | 11,543 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,531 | $3K |
| 82043 | <1% | 498 | $3K | |
| 93225 | <1% | 27 | $3K | |
| 81001 | <1% | 947 | $3K | |
| 85610 | <1% | 4,788 | $3K | |
| 0011A | <1% | 98 | $3K | |
| 85018 | <1% | 651 | $3K | |
| 85652 | <1% | 556 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 96 | $2K |
| 96376 | <1% | 2,019 | $2K | |
| 83880 | <1% | 1,173 | $2K | |
| 12011 | <1% | 14 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 713 | $2K |
| 84100 | <1% | 562 | $2K | |
| 73110 | <1% | 184 | $2K | |
| 97161 | <1% | 32 | $2K | |
| 83615 | <1% | 407 | $2K | |
| 99443 | <1% | 57 | $1K | |
| 84550 | <1% | 411 | $1K | |
| 92523 | <1% | 17 | $1K | |
| 83690 | <1% | 3,568 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 84 | $1K |
| 84146 | <1% | 80 | $1K | |
| 82565 | <1% | 146 | $1K | |
| 72072 | <1% | 30 | $1K | |
| 87507 | <1% | 15 | $1K | |
| 87077 | <1% | 669 | $1K | |
| 85379 | <1% | 1,410 | $894.52 | |
| 84132 | <1% | 684 | $886.79 | |
| 83655 | <1% | 57 | $854.34 | |
| 94664 | <1% | 1,049 | $848.80 | |
| 87186 | <1% | 434 | $804.81 | |
| 84153 | <1% | 69 | $773.11 | |
| 83605 | <1% | 1,692 | $765.24 | |
| 82550 | <1% | 241 | $743.53 | |
| 95806 | <1% | 12 | $709.91 | |
| 90686 | <1% | 29 | $693.03 | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $683.51 |
| 77080 | <1% | 12 | $681.28 | |
| 84156 | <1% | 209 | $665.04 | |
| 85730 | <1% | 1,106 | $637.61 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,584 | $637.36 |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 28 | $633.39 |
| 82105 | <1% | 41 | $583.80 | |
| 80074 | <1% | 55 | $531.14 | |
| J3490 | Unclassified drugs | <1% | 87 | $528.17 |
| 87040 | <1% | 668 | $514.62 | |
| 73080 | <1% | 20 | $504.35 | |
| 86038 | <1% | 27 | $494.34 | |
| 84403 | <1% | 38 | $450.00 | |
| 82784 | <1% | 41 | $406.94 | |
| 84145 | <1% | 469 | $389.10 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 193 | $370.15 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 433 | $367.80 |
| 71101 | <1% | 32 | $350.63 | |
| 82951 | <1% | 13 | $243.58 | |
| 82248 | <1% | 27 | $237.06 | |
| C9290 | Injection, bupivacaine liposome, 1 mg | <1% | 97 | $214.71 |
| 99442 | <1% | 21 | $189.77 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 100 | $160.96 |
| 90656 | <1% | 14 | $160.73 | |
| 82952 | <1% | 13 | $153.01 | |
| 84460 | <1% | 17 | $134.27 | |
| 73590 | <1% | 16 | $125.46 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 729 | $117.83 |
| 82077 | <1% | 145 | $115.69 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 379 | $54.54 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 89 | $48.93 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 679 | $47.47 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,871 | $43.12 |
| 82310 | <1% | 13 | $38.47 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 359 | $35.56 |
| J2704 | Injection, propofol, 10 mg | <1% | 691 | $35.13 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 126 | $32.63 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 172 | $31.95 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 213 | $29.28 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 289 | $24.13 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,166 | $19.27 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 926 | $13.88 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 762 | $13.66 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,467 | $12.72 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 802 | $10.23 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 98 | $10.01 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 92 | $8.39 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 217 | $5.49 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 231 | $5.24 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 36 | $5.15 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,474 | $4.59 |
| 81002 | <1% | 24 | $3.48 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 344 | $3.13 |
| 82803 | <1% | 95 | $3.10 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 391 | $2.05 |
| 91301 | <1% | 197 | $1.86 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 46 | $1.06 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 84 | $0.99 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 68 | $0.62 |
| 82150 | <1% | 56 | $0.28 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 30 | $0.24 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 831 | $0.00 |
| 94760 | 0% | 633 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 131 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 65 | $0.00 |
| 80047 | 0% | 13 | $0.00 | |
| 87205 | 0% | 16 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 0% | 27 | $0.00 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 20 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 70 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 100 | $0.00 |
| 73140 | 0% | 12 | $0.00 | |
| 29125 | 0% | 13 | $0.00 | |
| 82010 | 0% | 18 | $0.00 | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 15 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 12 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHARP, KEVIN (SR VP)
Parent organizationPROMEDICA HEALTH SYSTEM
| Provider | Location | Paid |
|---|---|---|
| The Toledo Hospital | Toledo, OH | $151.22M |
| Emma L. Bixby Medical Center | Adrian, MI | $18.35M |
| Community Health Center of Branch County | Coldwater, MI | $11.80M |
| Defiance Hospital INC. | Defiance, OH | $11.55M |
| Memorial Hospital | Fremont, OH | $11.40M |
| Fostoria Hospital Association | Fostoria, OH | $7.48M |
| Toledo Hospital | Toledo, OH | $2.38M |
| Herrick Memorial Hospital, INC. | Tecumseh, MI | $1.82M |
| Flower Hospital | Sylvania, OH | $368K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.